Old Web
English
Sign In
Acemap
>
Paper
>
193 Phase I Safety Experience with the Oral Pan-class I PI3K Inhibitor BKM120 in Patients with Metastatic Breast Cancer (mBC)
193 Phase I Safety Experience with the Oral Pan-class I PI3K Inhibitor BKM120 in Patients with Metastatic Breast Cancer (mBC)
2012
Cristina Saura
H. A. Burris
Carlos L. Arteaga
Ingrid A. Mayer
Caroline Germa
Nathalie Fretault
David Sternberg
Lucia Trandafir
Cristian Massacesi
Jordi Rodon
Keywords:
Oncology
Internal medicine
Medicine
Metastatic breast cancer
PI3K Inhibitor BKM120
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]